Ampio Pharma To Buy DMI Biosciences
The acquisition is expected to give Ampio access to all rights, royalties and patents associated with a drug that treats premature ejaculation (PE) recently licensed to a specialty
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of Cushing’s syndrome of endogenous origin.
Amira has successfully completed Phase 1 studies on its lead DP2 receptor antagonist, AM211, and anticipates that this compound will be developed for the treatment of respiratory diseases
The recommendation was made following discussions with Cell Therapeutics about the preclinical and clinical Pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may